Although Ki-67 is associated with EGFR mutation and poor survival outcomes for NSCLC patients, the relationship between Ki-67 expression and first-line EGFR-TKIs or chemotherapy in NSCLC patients has not been elucidated. The gene discussed is MKI67; the disease is non-small cell lung carcinoma.